Cellaria creates high quality, next generation in-vitro disease models that reflect the unique nature of a patient’s biology. All of our models begin with tissue from a patient, capturing clinically relevant details that inform model characterization. For cancer, Cellaria’s cell models exhibit molecular and phenotypic characteristics that are highly concordant to the patient. For RNA-mediated iPS cell line derivation, Cellaria’s cell models enable interrogation of disease-specific mechanisms of action.
Cellaria’s innovative products and services help lead the research community to more personalized therapeutics – revolutionizing and accelerating the search for a cure.
Company Details
- Founded
- 2013
- Address
- 9 Audubon Rd, Wakefield,massachusetts 01880,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cellariainc.com
- Keywords
- Cancer Cell Lines, Cell Culture Media, Custom Human Cancer Model Development, Patient-derived Cell Lines, Oncology Models, Serum-free Media, iPSC Services, Cell Models, Stem Cell Reprogramming, Custom Assay Development, Cell line Development, Cancer Research.
- HQ
- Wakefield, Massachusetts
Cellaria Questions
Cellaria's website is http://www.cellariainc.com
Cellaria's LinkedIn profile is https://www.linkedin.com/company/cellaria-inc
Cellaria's industry is
Biotechnology Research
Cellaria's categories are Biotechnology Research
Cellaria's founding year is 2013
